Masaharu Mori
Corporate Officer/Principal presso Laboratoires OncoTherapy Science France SARL
Posizioni attive di Masaharu Mori
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Laboratoires OncoTherapy Science France SARL | Corporate Officer/Principal | 01/10/2014 | - |
Storia della carriera di Masaharu Mori
Precedenti posizioni note di Masaharu Mori
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Direttore/Membro del Consiglio | 01/09/2014 | 27/02/2017 |
| Presidente | 01/09/2014 | 27/02/2017 | |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Direttore/Membro del Consiglio | 01/12/2014 | - |
| Presidente | 01/12/2014 | - | |
Dojin Iyaku-Kako Co., Ltd.
 Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Presidente | 26/09/2011 | - |
Statistiche
Distribuzione geografica
| Giappone | 4 |
| Francia | 2 |
Posizioni
| President | 3 |
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Health Technology |
| Laboratoires OncoTherapy Science France SARL | |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
- Borsa valori
- Insiders
- Masaharu Mori
- Esperienza
